BMP-2 Dependent Increase of Soft Tissue Density in Arthrofibrotic TKA

Arthrofibrosis after total knee arthroplasty (TKA) is difficult to treat, as its aetiology remains unclear. In a previous study, we established a connection between the BMP-2 concentration in the synovial fluid and arthrofibrosis after TKA. The hypothesis of the present study was, therefore, that the limited range of motion in arthrofibrosis is caused by BMP-2 induced heterotopic ossifications, the quantity of which is dependent on the BMP-2 concentration in the synovial fluid. Eight patients with arthrofibrosis after TKA were included. The concentration of BMP-2 in the synovial fluid from each patient was determined by ELISA. Radiologically, digital radiographs were evaluated and the grey scale values were determined as a measure of the tissue density of defined areas. Apart from air, cutis, subcutis and muscle, the soft-tissue density in the area of the capsule of the suprapatellar pouch was determined. The connection between the BMP-2 concentration and the soft-tissue density was then investigated. The average BMP-2 concentration in the synovial fluid was 24.3 ± 6.9 pg/ml. The density of the anterior knee capsule was on average 136 ± 35 grey scale values. A linear correlation was shown between the BMP-2 concentration in the synovial fluid and the radiological density of the anterior joint capsule (R=0.84, p = 0.009). We were able to show that there is a connection between BMP-2 concentration and soft-tissue density in arthrofibrosis after TKA. This opens up the possibility of conducting a prophylaxis against arthrofibrosis in risk patients by influencing the BMP-2 pathway.

[1]  G. Duda,et al.  Increased BMP expression in arthrofibrosis after TKA , 2012, Knee Surgery, Sports Traumatology, Arthroscopy.

[2]  Nesrine Z. Mostafa,et al.  Osteogenic Differentiation of Human Mesenchymal Stem Cells Cultured with Dexamethasone, Vitamin D3, Basic Fibroblast Growth Factor, and Bone Morphogenetic Protein-2 , 2012, Connective tissue research.

[3]  N. Faucheux,et al.  BMP‐9‐induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  E. Shore.  Osteoinductive signals and heterotopic ossification , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  F. Pohlig,et al.  [Heterotopic ossifications in total hip arthroplasty: prophylaxis and therapy]. , 2011, Der Orthopade.

[6]  R. Eisenhart-Rothe,et al.  Heterotope Ossifikationen im Rahmen der Hüftendoprothetik , 2011, Der Orthopäde.

[7]  C. Krettek,et al.  Heterotopic ossifications following implant surgery—epidemiology, therapeutical approaches and current concepts , 2011, Seminars in Immunopathology.

[8]  Vasilios A. Zerris,et al.  Cytokine-Mediated Inflammatory Reaction Following Posterior Cervical Decompression and Fusion Associated With Recombinant Human Bone Morphogenetic Protein-2: A Case Study , 2010, Spine.

[9]  T. Wright,et al.  Gene delivery of TGF-β1 induces arthrofibrosis and chondrometaplasia of synovium in vivo , 2010, Laboratory Investigation.

[10]  J. Parvizi,et al.  Mast cells and hypoxia drive tissue metaplasia and heterotopic ossification in idiopathic arthrofibrosis after total knee arthroplasty , 2010, Fibrogenesis & tissue repair.

[11]  E. Su,et al.  Stiffness after TKR: how to avoid repeat surgery. , 2010, Orthopedics.

[12]  P. Anderson,et al.  Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion. , 2010, The spine journal : official journal of the North American Spine Society.

[13]  M. Bronson,et al.  How to Treat the Stiff Total Knee Arthroplasty?: A Systematic Review , 2010, Clinical orthopaedics and related research.

[14]  J. Parvizi,et al.  Reactive oxygen and nitrogen species induce protein and DNA modifications driving arthrofibrosis following total knee arthroplasty , 2009, Fibrogenesis & tissue repair.

[15]  D. Lorich,et al.  Complications of Recombinant Human BMP-2 for Treating Complex Tibial Plateau Fractures: A Preliminary Report , 2009, Clinical orthopaedics and related research.

[16]  H. Yoshikawa,et al.  Stimulation of Ectopic Bone Formation in Response to BMP-2 by Rho Kinase Inhibitor: A Pilot Study , 2009, Clinical orthopaedics and related research.

[17]  Simone Cerciello,et al.  Stiffness in total knee arthroplasty , 2009, Journal of Orthopaedics and Traumatology.

[18]  Reinhilde Jacobs,et al.  Development of a clinically applicable tool for bone density assessment , 2009, International Journal of Computer Assisted Radiology and Surgery.

[19]  W. Sebald,et al.  Biological activity of a genetically modified BMP-2 variant with inhibitory activity , 2009, Head & face medicine.

[20]  C. Franke,et al.  [Indomethacin--short-term therapy vs. single low dosage radiation for prevention of periarticular ossifications after total hip endoprosthesis]. , 2008, Zeitschrift für Orthopädie und ihre Grenzgebiete.

[21]  J. Brand,et al.  Lokalisation von TGF-β und PDGF und deren Bedeutung für die Pathogenese der Arthrofibrose , 2008, Der Unfallchirurg.

[22]  A. Toom,et al.  Bone Formation Zones in Heterotopic Ossifications: Histologic Findings and Increased Expression of Bone Morphogenetic Protein 2 and Transforming Growth Factors ß2 and ß3 , 2007, Calcified Tissue International.

[23]  J. Parvizi,et al.  Management of stiffness following total knee arthroplasty. , 2006, The Journal of bone and joint surgery. American volume.

[24]  P. Neyret,et al.  Stiffness after total knee arthroplasty: prevalence, management and outcomes. , 2006, The Knee.

[25]  V. Bühren,et al.  Therapie der Arthrofibrose nach Kniegelenkendoprothetik , 2006, Der Orthopäde.

[26]  A. Giurea,et al.  Ossifikationsprophylaxe nach Hüft-TEP mit Indomethacin: Analyse von Risikofaktoren , 2005 .

[27]  Paul A Lotke,et al.  Stiffness after total knee arthroplasty. Prevalence of the complication and outcomes of revision. , 2004, The Journal of bone and joint surgery. American volume.

[28]  C. Krettek,et al.  Screening for arthrofibrosis after anterior cruciate ligament reconstruction: analysis of association with human leukocyte antigen. , 2004, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[29]  M. Ritter,et al.  Predicting Range of Motion After Total Knee Arthroplasty: Clustering, Log-Linear Regression, and Regression Tree Analysis , 2003, The Journal of bone and joint surgery. American volume.

[30]  M. Ries,et al.  Arthrofibrosis After Total Knee Arthroplasty , 2000, Clinical orthopaedics and related research.

[31]  B. K. Vaughn,et al.  Knee manipulation following total knee arthroplasty , 1991 .

[32]  N. Chen,et al.  Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. , 2010, Journal of neurosurgery. Spine.

[33]  P. Lobenhoffer,et al.  [Localisation of TGF-beta and PDGF and their relevance for the pathogenesis of arthrofibrosis]. , 2008, Der Unfallchirurg.

[34]  A. Adili,et al.  Predictive risk factors for stiff knees in total knee arthroplasty. , 2006, The Journal of arthroplasty.

[35]  J. Jerosch,et al.  Arthroscopic treatment of patients with moderate arthrofibrosis after total knee replacement , 2006, Knee Surgery, Sports Traumatology, Arthroscopy.

[36]  R. Burgkart,et al.  [Therapy of arthrofibrosis after total knee arthroplasty]. , 2006, Der Orthopade.

[37]  A. Giurea,et al.  [Prevention of heterotopic ossification after THA with indomethacin: analysis of risk factors]. , 2005, Zeitschrift fur Orthopadie und ihre Grenzgebiete.

[38]  B. K. Vaughn,et al.  Knee manipulation following total knee arthroplasty. Analysis of prognostic variables. , 1991, The Journal of arthroplasty.